• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Postpartum Hemorrhage Prophylaxis – Is IM or IV Route Better?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Charles et al. (BMC Pregnancy Childbirth, 2019) sought to determine the effectiveness and safety of 10 IU oxytocin administration techniques during the third stage of labor for PPH

METHODS:

  • Open-label, three-arm, parallel, randomized controlled trial (RCT)
  • Participants
    • Women delivering vaginally without exposure to pre-delivery uterotonics
  • Randomization to the following groups
    • Intramuscular (IM) injection (in thigh)
    • Intravenous (IV) infusion
      • Oxytocin mixed in 500 mL fluid | Gravity-driven infusion through an 18g needle
    • Intravenous (IV) bolus
      • Directly in to port over 1 minute
    • Primary outcomes
      • Mean postpartum blood loss (recorded 1 hour after delivery, using an objective measuring system)
      • Proportion of women with postpartum blood loss ≥500 ml
    • Side effects also documented, as well as demographics, obstetrical and intrapartum history

RESULTS:

  • 4,913 women were randomized
  • 2,104 IM injection | 2,108 via IV infusion | 701 via IV bolus
  • Compared to IM injection, mean blood loss was significantly reduced in IV arms
    • 5.9% less in the IV infusion arm (95% CI, -8.5, - 3.3)
    • 11.1% less in the IV bolus arm (95% CI, -14.7, - 7.8)
  • Compared to IM injection, risk of postpartum blood loss ≥500 ml was significantly reduced with IV infusion
    • Risk of PPH ≥500 ml: 0.8% vs. 1.5%
    • Relative risk (RR) 0.50 (95% CI, 0.27, 0.91)
  • Compared to IM injection, risk of postpartum blood loss ≥500 ml was reduced with IV bolus but not statistically significant
  • No side effects were reported in any arm

CONCLUSION:

  • IV oxytocin is more effective than IM injection in prevention of PPH in 3rd stage of labor
  • The authors acknowledge (1) lack of blinding and (2) lack of electrical IV pumps to be limitations
  • Authors state

If an IV line is already in place at delivery, IV infusion or IV bolus administration of oxytocin may be preferable to IM injection in the third stage of labor

  • Findings consistent with previous studies (see ‘Related ObG Topics’ below)

Learn More – Primary Sources:

Intramuscular injection, intravenous infusion, and intravenous bolus of oxytocin in the third stage of labor for prevention of postpartum hemorrhage: a three-arm randomized control trial.

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Postpartum Hemorrhage – Medications to Treat Uterine Atony 
Latest Cochrane Review: What is the Most Effective Prophylactic Treatment for Postpartum Hemorrhage?
Postpartum Hemorrhage Prophylaxis: The World Health Organization Recommendations
Intramuscular or Intravenous Oxytocin to Prevent Postpartum Hemorrhage?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site